NTI

Hollywood Voices Sound Alarm on Nuclear Threat as Oppenheimer Sweeps the Academy Awards

Retrieved on: 
Monday, March 11, 2024
Defense, Other Defense, Film & Motion Pictures, Energy, Celebrity, Events, Concerts, Nuclear, Entertainment, Letter, Anglo-French Wars, History, Nuclear weapon, Originality, Nuclear Threat Initiative, Weeping Angel, Multimedia, Conventional weapon, NTI, Film industry

Murphy’s Oscars message came amid the Nuclear Threat Initiative ’s Los Angeles-based campaign to leverage attention on the film to underscore that while Oppenheimer is history, nuclear weapons are not.

Key Points: 
  • Murphy’s Oscars message came amid the Nuclear Threat Initiative ’s Los Angeles-based campaign to leverage attention on the film to underscore that while Oppenheimer is history, nuclear weapons are not.
  • The letter was also signed by Hollywood luminaries like Michael Douglas and Jane Fonda as well as Oppenheimer cast members Matthew Modine and Tony Goldwyn.
  • “The film brought nuclear weapons to the big screen and helped raise awareness about today’s nuclear threats.
  • Hollywood can play a transformative role in educating audiences about the risks and helping us imagine a safer future without nuclear weapons.

Tejas Networks announces strategic partnership with Telecom Egypt

Retrieved on: 
Tuesday, March 26, 2024
Knowledge, National Knowledge Network, Organization, NKN, Information technology, Digital, Telecom Egypt, Partnership, Communication, Memorandum of understanding, Investment, Ecosystem, FTTH, Tejas Networks, Telecom, Tata Group, MEA, NTI, Mobile phone

Hon'ble Dr. Amr Talaat, Minister of Communications and Information Technology of Egypt, said, "Today's MoU with Tejas Networks is one of the fruits of discussions that began in January 2023 to enhance cooperation between Egypt and India in the field of communications and information technology.

Key Points: 
  • Hon'ble Dr. Amr Talaat, Minister of Communications and Information Technology of Egypt, said, "Today's MoU with Tejas Networks is one of the fruits of discussions that began in January 2023 to enhance cooperation between Egypt and India in the field of communications and information technology.
  • Mohamed Nasr El-Din, CEO and Managing Director of Telecom Egypt, said, "We are delighted to enter into a long-term strategic partnership with Tejas Networks, India's leading R&D-driven telecom and networking products company and a part of the Tata Group.
  • Telecom Egypt has been consistently working towards enhancing its network infrastructure and developing its technical capabilities through cooperation with the largest companies in the world.
  • This MoU provides a great platform for us to expand our business in MEA while deepening our collaboration with Telecom Egypt and other customers in the country."

Tejas Networks announces strategic partnership with Telecom Egypt

Retrieved on: 
Tuesday, March 26, 2024
Knowledge, National Knowledge Network, Organization, NKN, Information technology, Digital, Telecom Egypt, Partnership, Communication, Memorandum of understanding, Investment, Ecosystem, FTTH, Tejas Networks, Telecom, Tata Group, MEA, NTI, Mobile phone

Hon'ble Dr. Amr Talaat, Minister of Communications and Information Technology of Egypt, said, "Today's MoU with Tejas Networks is one of the fruits of discussions that began in January 2023 to enhance cooperation between Egypt and India in the field of communications and information technology.

Key Points: 
  • Hon'ble Dr. Amr Talaat, Minister of Communications and Information Technology of Egypt, said, "Today's MoU with Tejas Networks is one of the fruits of discussions that began in January 2023 to enhance cooperation between Egypt and India in the field of communications and information technology.
  • Mohamed Nasr El-Din, CEO and Managing Director of Telecom Egypt, said, "We are delighted to enter into a long-term strategic partnership with Tejas Networks, India's leading R&D-driven telecom and networking products company and a part of the Tata Group.
  • Telecom Egypt has been consistently working towards enhancing its network infrastructure and developing its technical capabilities through cooperation with the largest companies in the world.
  • This MoU provides a great platform for us to expand our business in MEA while deepening our collaboration with Telecom Egypt and other customers in the country."

Provell Pharmaceuticals and Mark Cuban Cost Plus Drug Company Bring Leading Hypothyroid Drug, Euthyrox®, to U.S. Patients at Low-Cost Prices through Direct-to-Consumer Model

Retrieved on: 
Tuesday, March 12, 2024
Health, Hypothyroidism, Entrepreneurship, Disease, Partnership, Patient, Pharmacy, Merck, HONEY, Doctor of Philosophy, MD, Insurance, Merck Group, PBC, Plasma protein binding, Cost Plus Drugs, Blister, Marketing, FDA, NTI, Physician, World Market (store), Medicine, Pharmaceutical industry

HONEY BROOK, Pa., March 12, 2024 /PRNewswire/ -- Provell Pharmaceuticals, a healthcare company that distributes world-class, branded drugs at generic prices by eliminating middlemen markups, today announced a partnership with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) to offer patients direct access to a leading hypothyroid drug, Euthyrox®, at low-cost prices on the Cost Plus Drugs online platform.

Key Points: 
  • HONEY BROOK, Pa., March 12, 2024 /PRNewswire/ -- Provell Pharmaceuticals, a healthcare company that distributes world-class, branded drugs at generic prices by eliminating middlemen markups, today announced a partnership with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) to offer patients direct access to a leading hypothyroid drug, Euthyrox®, at low-cost prices on the Cost Plus Drugs online platform.
  • It is now offered in the U.S. through Cost Plus Drugs and in retail pharmacies.
  • "By working directly with online platforms such as Cost Plus Drugs, which shares our vision to make drugs affordable and accessible to all, we are disrupting the traditional model and conferring significant savings to patients."
  • Currently, the U.S. healthcare system consists of complex pricing mechanisms, for both brand and generic medications, that artificially inflate prices.

Nuclear Threat Initiative Launches “Make Nukes History” Campaign to Spotlight Nuclear Weapon Risks Ahead of Academy Awards

Retrieved on: 
Wednesday, March 6, 2024
Entertainment, Other Energy, Events, Concerts, Nuclear, Energy, General Entertainment, Film & Motion Pictures, Celebrity, Other Philanthropy, Philanthropy, Defense, Other Defense, Contracts, Foundation, Weeping Angel, Soil, Weapon, Social media, Nuclear Threat Initiative, Letter, Risk, Anglo-French Wars, Attention, History, Modine, NTI, Academy Awards, Conventional weapon, Partnership, Film industry

The Nuclear Threat Initiative (NTI) launched a “Make Nukes History” campaign today in Los Angeles, leveraging the attention on Christopher Nolan’s Oscar-nominated film Oppenheimer to elevate the conversation about the nuclear threat in the run-up to the Academy Awards.

Key Points: 
  • The Nuclear Threat Initiative (NTI) launched a “Make Nukes History” campaign today in Los Angeles, leveraging the attention on Christopher Nolan’s Oscar-nominated film Oppenheimer to elevate the conversation about the nuclear threat in the run-up to the Academy Awards.
  • In the letter, the artists and advocates said, “We want to raise our voices to remind people that while Oppenheimer is history, nuclear weapons are not.
  • “Today, nine countries hold 13,000 nuclear weapons, a new arms race is underway and nuclear sabre-rattling has reappeared.
  • Modine has also produced the new documentary feature Downwind about the impact of nuclear weapons testing during the Cold War.

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Retrieved on: 
Tuesday, March 5, 2024
Technology, Diabetes, Health, Apps, Applications, Pharmaceutical, Mental Health, Telemedicine, Virtual Medicine, Medical Devices, Software, General Health, Health Technology, Fitness & Nutrition, Clinical Trials, Cardiology, T2D, Nutrition, Randomized controlled trial, Education, Conditional sentence, Obesity, FDA, Food, White House conference, CHC, Federally Qualified Health Center, A1C, Conference, ACLM, Better, Therapy, Type 2 diabetes, American College, Food and Drug Administration, Patient, NTI, RCT, Medicine, Society, Harvard Medical School, Community health center, Prescription, FQHC, Partnership, Pharmaceutical industry

Through this partnership, Better Therapeutics is committed to making one million prescriptions of its U.S. Food and Drug Administration (FDA)-authorized product, AspyreRx , available to support underserved patients through 1,400 Federally Qualified Health Center (FQHC) organizations.

Key Points: 
  • Through this partnership, Better Therapeutics is committed to making one million prescriptions of its U.S. Food and Drug Administration (FDA)-authorized product, AspyreRx , available to support underserved patients through 1,400 Federally Qualified Health Center (FQHC) organizations.
  • This underscores the urgent need for evidence-based interventions to ensure equitable access to high-quality care for all.
  • The Lifestyle Medicine National Training Initiative (NTI) is an extension of ACLM’s $24.1 million commitment to the 2022 White House Conference on Hunger, Health, and Nutrition .
  • Better Therapeutics and ACLM are seeking additional partners and funding to support the implementation and maximize the initiative’s impact.

BCV Raises €6M Series A

Retrieved on: 
Wednesday, December 13, 2023
Research, General Health, Professional Services, Medical Devices, Technology, Other Professional Services, Clinical Trials, Science, Biotechnology, Finance, Other Technology, Health, Peripheral artery disease, Safety, FAHA, NTI, Multimedia, Partner, FDA, FACS, CE, Stroke, Miniaturization, Lead, MD, Doctor of Philosophy, Gesture, BCV, Reims

This Series A funding brings the total amount raised since inception to €13M.

Key Points: 
  • This Series A funding brings the total amount raised since inception to €13M.
  • “Our technology, applied to a guidewire, will be a disruptive change in minimally invasive procedures improving patients’ outcomes,” says Raphaël Blanc, M.D., Chairman & Co-Founder, BCV.
  • “This round of financing will enable BCV to progress toward FDA and CE mark approval,” adds Thierry Col, CEO, BCV.
  • The BCV system’s shape-memory alloy technology enables distal tip control improving practitioners’ gestures and demonstrating superior performance over existing advanced actuation technologies.

National Reconnaissance Office (NRO) Awards Albedo Electro-Optical Capabilities Contract

Retrieved on: 
Tuesday, December 5, 2023
Satellite, Defense, Audio, Video, Contracts, Electronic Design Automation, Technology, Aerospace, Manufacturing, LWIR, Albedo, National Imagery Transmission Format, BAA, Commercial, NTI, Collection, NIIRS, NRO, NEI, Intelligence, VLEO, CEC, EO, Framework

Albedo will collaborate closely with NRO to provide both near and long-term EO remote sensing capabilities via modeling, simulation, and data evaluation.

Key Points: 
  • Albedo will collaborate closely with NRO to provide both near and long-term EO remote sensing capabilities via modeling, simulation, and data evaluation.
  • This effort will conduct accuracy and quality assessments such as the National Imagery Interpretability Rating Scale (NIIRS), which measures the clarity of images from satellites.
  • Furthermore, Albedo also plans to provide Nighttime Imaging (NTI), Non-Earth Imaging (NEI), and video using its thermal LWIR sensor commercial capabilities.
  • Albedo also plans to fulfill ad-hoc product ordering and delivery requests from the NRO and their partners.

American College of Lifestyle Medicine commits over $2 million to train physicians who provide care to patients disproportionately at-risk for chronic disease

Retrieved on: 
Thursday, December 14, 2023
Medicine, Nutrition, Community health center, Health system, Behavior, Organization, Prevalence, Food, ACE, FACSM, NTI, Kidney failure, Community, American Council, Patient, Type 2 diabetes, Obesity, American College, National Association, Conditional sentence, Harvard Medical School, Conference, White House conference, FQHC, Diabetes, Knowledge, Physician, Initiative, Paratriathlon, Travel, Education, CHC, Pharmaceutical industry, Nursing, ACLM, Hunger, MD, Health, Exercise

ST. LOUIS, Dec. 14, 2023 /PRNewswire/ -- The American College of Lifestyle Medicine (ACLM) today announced the Lifestyle Medicine National Training Initiative (NTI), a commitment of more than $2 million in matching funds to train and certify, at minimum, one physician in lifestyle medicine within each Federally Qualified Health Center (FQHC) and Community Health Center (CHC) across the United States. The scholarship effort, which includes partnerships with national and community-based organizations including the first impact partner, the American Council on Exercise (ACE), will expand access to lifestyle medicine in historically under-resourced communities.

Key Points: 
  • The scholarship effort, which includes partnerships with national and community-based organizations, will expand access to lifestyle medicine in under-resourced communities.
  • Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes and obesity.
  • Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions.
  • "The National Training Initiative is a major step in the right direction in making lifestyle medicine accessible to all."

American College of Lifestyle Medicine commits over $2 million to train physicians who provide care to patients disproportionately at-risk for chronic disease

Retrieved on: 
Thursday, December 14, 2023
Medicine, Nutrition, Community health center, Health system, Behavior, Organization, Prevalence, Food, ACE, FACSM, NTI, Kidney failure, Community, American Council, Patient, Type 2 diabetes, Obesity, American College, National Association, Conditional sentence, Conference, White House conference, Harvard Medical School, FQHC, Diabetes, Knowledge, Physician, Initiative, Paratriathlon, Travel, Education, CHC, Pharmaceutical industry, Nursing, ACLM, Hunger, MD, Health, Exercise

ST. LOUIS, Dec. 14, 2023 /PRNewswire-PRWeb/ --The American College of Lifestyle Medicine (ACLM) today announced the Lifestyle Medicine National Training Initiative (NTI), a commitment of more than $2 million in matching funds to train and certify, at minimum, one physician in lifestyle medicine within each Federally Qualified Health Center (FQHC) and Community Health Center (CHC) across the United States. The scholarship effort, which includes partnerships with national and community-based organizations including the first impact partner, the American Council on Exercise (ACE), will expand access to lifestyle medicine in historically under-resourced communities.

Key Points: 
  • The scholarship effort, which includes partnerships with national and community-based organizations, will expand access to lifestyle medicine in under-resourced communities.
  • Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes and obesity.
  • Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions.
  • "The National Training Initiative is a major step in the right direction in making lifestyle medicine accessible to all."